Methylphenidate in depressed medically ill patients

Paul B Rosenberg, I. Ahmed, S. Hurwitz

Research output: Contribution to journalArticle

Abstract

Background: The purpose of the authors' study was to evaluate the efficacy of methylphenidate in the medically ill depressed patients and to examine the factors that appear to affect therapeutic response and side effects. Method: Hospital charts were reviewed for 29 patients who received trials of methylphenidate for treatment of depressive disorders while admitted to a medical/surgical unit. Results: Of the 29 patients, 16 (55%) had moderate or marked improvement, all within 2 days of commencing treatment with the maximal dose. Of the 25 nondelirious patients, 16 (64%) had moderate or marked improvement, and the presence of delirium was significantly associated with decreased response. Therapeutic response was significantly correlated with maximum methylphenidate dose. Side effects were noted in 8 (28%) patients; most side effects were mild (tachycardia or agitation), and all reversed after the medication was discontinued. Conclusions: Methylphenidate provides a safe and effective alternative to tricyclic antidepressants in medically ill populations but appears to be less effective in the presence of delirium.

Original languageEnglish (US)
Pages (from-to)263-267
Number of pages5
JournalJournal of Clinical Psychiatry
Volume52
Issue number6
StatePublished - 1991
Externally publishedYes

Fingerprint

Methylphenidate
Delirium
Tricyclic Antidepressive Agents
Therapeutics
Depressive Disorder
Tachycardia
Population

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Methylphenidate in depressed medically ill patients. / Rosenberg, Paul B; Ahmed, I.; Hurwitz, S.

In: Journal of Clinical Psychiatry, Vol. 52, No. 6, 1991, p. 263-267.

Research output: Contribution to journalArticle

Rosenberg, PB, Ahmed, I & Hurwitz, S 1991, 'Methylphenidate in depressed medically ill patients', Journal of Clinical Psychiatry, vol. 52, no. 6, pp. 263-267.
Rosenberg, Paul B ; Ahmed, I. ; Hurwitz, S. / Methylphenidate in depressed medically ill patients. In: Journal of Clinical Psychiatry. 1991 ; Vol. 52, No. 6. pp. 263-267.
@article{d2066f1738964e92b291868e2cba8931,
title = "Methylphenidate in depressed medically ill patients",
abstract = "Background: The purpose of the authors' study was to evaluate the efficacy of methylphenidate in the medically ill depressed patients and to examine the factors that appear to affect therapeutic response and side effects. Method: Hospital charts were reviewed for 29 patients who received trials of methylphenidate for treatment of depressive disorders while admitted to a medical/surgical unit. Results: Of the 29 patients, 16 (55{\%}) had moderate or marked improvement, all within 2 days of commencing treatment with the maximal dose. Of the 25 nondelirious patients, 16 (64{\%}) had moderate or marked improvement, and the presence of delirium was significantly associated with decreased response. Therapeutic response was significantly correlated with maximum methylphenidate dose. Side effects were noted in 8 (28{\%}) patients; most side effects were mild (tachycardia or agitation), and all reversed after the medication was discontinued. Conclusions: Methylphenidate provides a safe and effective alternative to tricyclic antidepressants in medically ill populations but appears to be less effective in the presence of delirium.",
author = "Rosenberg, {Paul B} and I. Ahmed and S. Hurwitz",
year = "1991",
language = "English (US)",
volume = "52",
pages = "263--267",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "6",

}

TY - JOUR

T1 - Methylphenidate in depressed medically ill patients

AU - Rosenberg, Paul B

AU - Ahmed, I.

AU - Hurwitz, S.

PY - 1991

Y1 - 1991

N2 - Background: The purpose of the authors' study was to evaluate the efficacy of methylphenidate in the medically ill depressed patients and to examine the factors that appear to affect therapeutic response and side effects. Method: Hospital charts were reviewed for 29 patients who received trials of methylphenidate for treatment of depressive disorders while admitted to a medical/surgical unit. Results: Of the 29 patients, 16 (55%) had moderate or marked improvement, all within 2 days of commencing treatment with the maximal dose. Of the 25 nondelirious patients, 16 (64%) had moderate or marked improvement, and the presence of delirium was significantly associated with decreased response. Therapeutic response was significantly correlated with maximum methylphenidate dose. Side effects were noted in 8 (28%) patients; most side effects were mild (tachycardia or agitation), and all reversed after the medication was discontinued. Conclusions: Methylphenidate provides a safe and effective alternative to tricyclic antidepressants in medically ill populations but appears to be less effective in the presence of delirium.

AB - Background: The purpose of the authors' study was to evaluate the efficacy of methylphenidate in the medically ill depressed patients and to examine the factors that appear to affect therapeutic response and side effects. Method: Hospital charts were reviewed for 29 patients who received trials of methylphenidate for treatment of depressive disorders while admitted to a medical/surgical unit. Results: Of the 29 patients, 16 (55%) had moderate or marked improvement, all within 2 days of commencing treatment with the maximal dose. Of the 25 nondelirious patients, 16 (64%) had moderate or marked improvement, and the presence of delirium was significantly associated with decreased response. Therapeutic response was significantly correlated with maximum methylphenidate dose. Side effects were noted in 8 (28%) patients; most side effects were mild (tachycardia or agitation), and all reversed after the medication was discontinued. Conclusions: Methylphenidate provides a safe and effective alternative to tricyclic antidepressants in medically ill populations but appears to be less effective in the presence of delirium.

UR - http://www.scopus.com/inward/record.url?scp=0025887634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025887634&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 263

EP - 267

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 6

ER -